These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 7101246)

  • 1. Immobilized heparin: spacer arm effects on biological interactions.
    Ebert CD; Kim SW
    Thromb Res; 1982 Apr; 26(1):43-57. PubMed ID: 7101246
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of protein adsorption on the anticoagulant activity of surface immobilized heparin.
    van Delden CJ; Engbers GH; Feijen J
    J Biomater Sci Polym Ed; 1996; 7(8):727-40. PubMed ID: 8639481
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and antithrombogenicity of heparinized polyurethanes with intervening spacer chains of various kinds.
    Liu LS; Ito Y; Imanishi Y
    Biomaterials; 1991 May; 12(4):390-6. PubMed ID: 1888808
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Coimmobilization of heparin/fibronectin mixture on titanium surfaces and their blood compatibility.
    Li G; Zhang F; Liao Y; Yang P; Huang N
    Colloids Surf B Biointerfaces; 2010 Nov; 81(1):255-62. PubMed ID: 20692134
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Surface modification with an antithrombin-heparin complex for anticoagulation: studies on a model surface with gold as substrate.
    Sask KN; Zhitomirsky I; Berry LR; Chan AK; Brash JL
    Acta Biomater; 2010 Aug; 6(8):2911-9. PubMed ID: 20197127
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immobilization of an antithrombin-heparin complex on gold: anticoagulant properties and platelet interactions.
    Sask KN; McClung WG; Berry LR; Chan AK; Brash JL
    Acta Biomater; 2011 May; 7(5):2029-34. PubMed ID: 21277398
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and anticoagulant activity of heparin immobilized "end-on" to polystyrene microspheres coated with end-group activated polyethylene oxide.
    Fry AK; Schilke KF; McGuire J; Bird KE
    J Biomed Mater Res B Appl Biomater; 2010 Jul; 94(1):187-95. PubMed ID: 20524194
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects on platelets and on the clotting system of four glycosaminoglycans extracted from hog mucosa and one extracted from aortic intima of the calf.
    Cella G; Scattolo N; Luzzatto G; Stevanato F; Vio C; Girolami A
    J Med; 1986; 17(5-6):331-46. PubMed ID: 2953835
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Heparin as a molecular spacer immobilized on microspheres to improve blood compatibility in hemoperfusion.
    Dang Q; Li CG; Jin XX; Zhao YJ; Wang X
    Carbohydr Polym; 2019 Feb; 205():89-97. PubMed ID: 30446153
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lack of in vitro interaction between heparin and nitroglycerin.
    Barnes AD; Horn JR; Wittkowsky AK
    Am J Clin Pathol; 1996 Mar; 105(3):298-300. PubMed ID: 8602610
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro blood compatibility of heparin-immobilized polyurethane containing ester groups in the side chain.
    Wan M; Baek DK; Cho JH; Kang IK; Kim KH
    J Mater Sci Mater Med; 2004 Oct; 15(10):1079-87. PubMed ID: 15516868
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of calcium ions on the activated partial thromboplastin time of heparinized plasma.
    Greenberg CS; Adams JP; Mullen PE; Koepke JA
    Am J Clin Pathol; 1986 Oct; 86(4):484-9. PubMed ID: 3766461
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Can heparin immobilized surfaces maintain nonthrombogenic activity during in vivo long-term implantation?
    Nojiri C; Kido T; Sugiyama T; Horiuchi K; Kijima T; Hagiwara K; Kuribayashi E; Nogawa A; Ogiwara K; Akutsu T
    ASAIO J; 1996; 42(5):M468-75. PubMed ID: 8944925
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Poly(dimethylsiloxane)-poly(ethylene oxide)-heparin block copolymers. II: Surface characterization and in vitro assessments.
    Grainger DW; Knutson K; Kim SW; Feijen J
    J Biomed Mater Res; 1990 Apr; 24(4):403-31. PubMed ID: 2347871
    [TBL] [Abstract][Full Text] [Related]  

  • 15. At high heparin concentrations, protamine concentrations which reverse heparin anticoagulant effects are insufficient to reverse heparin anti-platelet effects.
    Carr ME; Carr SL
    Thromb Res; 1994 Sep; 75(6):617-30. PubMed ID: 7831681
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Catalytic activity and platelet reactivity of heparin covalently bonded to surfaces.
    Lindon JN; Salzman EW; Merrill EW; Dincer AK; Labarre D; Bauer KA; Rosenberg RR
    J Lab Clin Med; 1985 Feb; 105(2):219-26. PubMed ID: 3973461
    [TBL] [Abstract][Full Text] [Related]  

  • 17. On the mechanism of coagulation inhibition on surfaces with end point immobilized heparin.
    Elgue G; Blombäck M; Olsson P; Riesenfeld J
    Thromb Haemost; 1993 Aug; 70(2):289-93. PubMed ID: 8236137
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The APTT response of pregnant plasma to unfractionated heparin.
    Chunilal SD; Young E; Johnston MA; Robertson C; Naguit I; Stevens P; Galashan D; Oskamp ML; Brennan B; Ginsberg JS
    Thromb Haemost; 2002 Jan; 87(1):92-7. PubMed ID: 11848463
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Construction and hemocompatibility study of highly bioactive heparin-functionalized surface.
    Yang ZL; Zhou S; Lu L; Wang X; Wang J; Huang N
    J Biomed Mater Res A; 2012 Nov; 100(11):3124-33. PubMed ID: 22815121
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anticoagulant effect of unfractionated heparin in antithrombin-depleted plasma in vitro.
    Krulder JW; Strebus AF; Meinders AE; Briët E
    Haemostasis; 1996; 26(2):85-9. PubMed ID: 9119287
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.